Feske lab at NYU
@Feskelab
Followers
292
Following
40
Media
58
Statuses
120
The Feske lab studies how ion channels transporting calcium and other ions regulate immunity to infection, tumors and cause autoimmunity in humans and mice.
Manhattan, New York, NY
Joined May 2018
RT @NoyerLucile: I’m excited to share our new paper published in @SciImmunology ! Together with @Liwei_K, we show that CLNS1A is essential….
0
1
0
RT @SciImmunology: New research from @Feskelab suggests that chloride nucleotide-sensitive channel 1A (CLNS1A) is a key transcriptional and….
0
27
0
Looking forward to hosting Dr. Min Peng tomorrow, June 18 at 11AM ET, for our next ICTI webinar at @NYUGSOM_Path! He’ll share new insights into ER calcium channels in T cells and how they might unlock new therapeutic strategies. Don’t miss it!.#ICTI #CTISRC #ImmunoChannels
0
4
9
Join us on May 15, 2025, from 11 AM to 12 PM for the next ICTI seminar at @NYUGSOM_Path featuring Dr. Nicolas Demaurex. He will discuss the regulation and function of store-operated and mechanosensitive Ca²⁺ channels in immune cells, with a focus on neutrophils #ICTI #CTISRC
0
1
3
Thank you, @bimald, for the lecture on TRPM7 channels in Endolysosomal Physiology of Macrophages. It was an incredibly insightful presentation. As we plan for the next academic year, we welcome speaker suggestions! If you have any recommendations, please feel free to share them!
0
0
5
Join us on April 3, 2025, for the next ICTI Research Seminar at @NYUGSOM_Path! Dr. @bimald will discuss “Ion channel TRPM7 in Endolysosomal Physiology of Macrophages”, focusing on the critical role of TRPM7 in immune cell function and its implications for immunomodulation. #ICTI
0
2
8
Dr. Chiu @IsaacChiuLab gave a brilliant talk on the role of TRPV1+ nociceptor neurons in host defense and barrier immunity. Read the full publication here:.A huge thank you to Dr. Chiu for sharing his insights with our @NYUGSOM_Path community!
0
1
7
Prof. Isaac Chiu @IsaacChiuLab will be presenting at our next ICTI Seminar on "Nociceptor neurons in host defense and barrier immunity" at @NYUGSOM_Path. Join us on February 27th, 2025, at 11 AM EST. Zoom link available upon request!
0
3
13
We are excited to announce our latest study published in @ScienceTM! We show that dysfunctional regulatory T cells drive Sjögren’s disease via IFN-gamma producing Th1 cells. Baricitinib inhibits IFN signaling and significantly alleviates symptoms, offering new hope for patients.
2
3
15
We are pleased to host Prof. Susanna Zierler at @NYUGSOM_Path for our next ICTI webinar on "The TRPM7 channel-kinase in immune cell function & inflammatory diseases". Join us tomorrow, December 11th, 2024, at 11am EST, zoom link upon request!
0
1
4
Thanks to everyone who attended the IonLab Open House at @NYUGSOM_Path! The event was a huge success! We're excited to start using the QPatch II system from @sophionbio and explore new collaborations with the IonLab. More updates coming soon! #IonLab #NYUGSOM
0
2
8
The IonLab at @NYUGSOM_Path has received the NIH S10 grant for the @sophionbio Automated Patch-Clamp System! Join us for an Open House on August 2nd, 2-5 PM to learn more about the new QPatch II system and explore potential collaborations. See you there!
0
1
9
The Feske Lab is on fire at the Channels and Transporters in Immunity FASEB conference! #CTISRC #FASEBconference #ICTImmunityConference
0
2
21
RT @thebiocalendar: Two in one! Visit @FASEBorg's inaugural conference on Channels and Transporters in Immunity, taking place June 16-20 in….
0
3
0
Here we go, Channels and Transporters in Immunity FASEB conference! Our keynote speaker, Dr. Michael Cahalan, is presenting an incredible overview on ion channels and calcium signaling in T lymphocytes. #CTISRC #FASEBconference #ICTImmunityConference .@bimald
0
5
16
Almost there! Join us for the Channels and Transporters in Immunity FASEB conference. Engage in enriching scientific discussions through talks, meet-the-expert sessions, and poster presentations. Co-located with the Immunoreceptor and Immunotherapy FASEB conference. See you soon!
1
0
2
0
0
0